Last Price$10.26Cboe Real-Time Last Sale as of 10:09AM ET 6/27/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.18(1.72%)
Bid (Size)$10.26 (206)
Ask (Size)$10.27 (33)
Day Low / High$10.17 - 10.54
Volume100.5 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 06/27/2022



Price: $10.26
Change: -0.18 (1.72%)
Volume: 100.5 K
10:09AM ET 6/27/2022

Kura Oncology Inc ( NASDAQ )

Price: $17.45
Change: -0.72 (3.96%)
Volume: 34.1 K
10:05AM ET 6/27/2022

Vericel Corp ( NASDAQ )

Price: $25.42
Change: -0.28 (1.09%)
Volume: 23.9 K
10:08AM ET 6/27/2022

Agios Pharmaceuticals Inc ( NASDAQ )

Price: $22.64
Change: +0.07 (0.31%)
Volume: 65.7 K
10:10AM ET 6/27/2022

Reata Pharmaceuticals Inc ( NASDAQ )

Price: $32.08
Change: +1.00 (3.22%)
Volume: 18.6 K
10:04AM ET 6/27/2022

Read more news Recent News

Insider Buy: Iveric Bio
5:05PM ET 6/14/2022 MT Newswires

Calvin W. Roberts, Director, on June 13, 2022, executed a purchase for 25,000 shares in Iveric Bio (ISEE) for $240,500. Following the Form 4 filing with...

IVERIC Bio Shares Rise After BofA Securities, Guggenheim Start Coverage at Buy
1:02PM ET 6/08/2022 MT Newswires

IVERIC Bio (ISEE) shares were up 2.6% in Wednesday midday trading after BofA Securities started coverage of the company with a buy rating and $18 price...

--Guggenheim Starts IVERIC bio at Buy With $30 Price Target
8:09AM ET 6/08/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

BofA Securities Starts IVERIC bio at Buy With $18 Price Target
6:31AM ET 6/08/2022 MT Newswires

IVERIC bio (ISEE) has an average rating of outperform and price targets ranging from $12 to $28, according to analysts polled by Capital IQ. (MT Newswires...

View all Commentary and Analysis

IVERIC bio: A First Take
2:16PM ET 6/23/2022 Seeking Alpha

Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
2:30PM ET 6/08/2022 Seeking Alpha

IVERIC (ISEE) Investor presentation - Slideshow
10:10AM ET 5/07/2022 Seeking Alpha

IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2022 Results - Earnings Call Transcript
2:04PM ET 5/04/2022 Seeking Alpha

Company Profile

Business DescriptionIVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. View company web site for more details
Address8 Sylvan Way
Parsippany, New Jersey 07054
Number of Employees35
Recent SEC Filing06/14/20224
Chief Executive Officer & DirectorGlenn P. Sblendorio
PresidentPravin U. Dugel
Chief Operating Officer & Senior Vice PresidentKeith Westby
Chief Financial Officer, Treasurer & Senior VPDavid F. Carroll

Company Highlights

Price Open$10.44
Previous Close$10.44
52 Week Range$5.96 - 19.35
Market Capitalization$1.2 B
Shares Outstanding116.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.13
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-46.15%

Analyst Ratings as of 06/08/2022

Consensus RecommendationConsensus Icon
Powered by Factset